Blood test for early detection of bile duct cancer
Part of Cancer, Digestive system clinical trials.
This study is testing a new blood test that looks for signs of DNA changes linked to biliary tract cancer. It aims to see if the test can find these cancers early. If you have biliary tract cancer or a high suspicion of it, you may be able to help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You need to have a confirmed diagnosis of biliary tract cancer (cancer of the bile ducts or gallbladder).
- You must be in reasonably good health, with stable vital signs and able to perform daily activities (ECOG 0-1).
- Your liver, kidney, and blood counts must meet certain lab levels (your doctor can check these).
- You cannot have had cancer treatment in the last 3 years, and you cannot have another active cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is collecting information and blood samples from people with biliary tract cancer to understand how certain markers and quality-of-life measures relate to treatment outcomes. The findings may help improve future care and support.
This study aims to find new ways to detect liver, bile duct, and pancreatic cancers early using a blood test. It may help doctors diagnose these cancers sooner, when they are easier to treat.
This study is testing a new blood test to help find cholangiocarcinoma (bile duct cancer) earlier and more easily. If you are scheduled for surgery for this cancer, this test may help confirm the diagnosis without more invasive procedures.
This study uses a simple blood test (ctDNA) to learn more about the genetic makeup of advanced biliary tract cancers. It may help researchers understand how these cancers respond to treatment, and it doesn't involve any extra drugs or procedures—just blood draws.
This study looks at whether a bile sample and a blood sample can show the same gene changes found in a tumor biopsy for people with bile duct or gallbladder cancer. It aims to see if these simpler tests could be used instead of a tumor tissue sample.
This study looks for new ways to measure cancer-related “biomarkers” (signals in blood or tumor samples) in people with bile duct cancer or gallbladder cancer. The goal is to improve how these cancers are identified and tracked, which could help doctors make better treatment decisions.
Hear when a new Gall Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.